CAS No.: 1338806-73-7
CFI-400945 Catalog No. CSN15736
Synonyms: CFI-400945 Free Base
CFI400945 is a potent and selective,orally bioavailable PLK4 inhibitor with an IC50 value of 2.8 ±1.4 nM have potential antineoplastic activity.
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
- 描述
- 细胞研究
- Cell Data
- 更多
- 临床研究
NCT号 适应症或疾病 临床期 招募状态 预计完成时间 地点 NCT03624543 Breast Cancer Phase 2 Not yet recruiting December 31, 2020 - NCT01954316 Advanced Cancer Phase 1 Recruiting September 2018 United States, California ... more >> UCLA Medical Center Recruiting Santa Monica, California, United States, 90404 Contact: Lisa Yonemoto 310-582-4069 lyonemoto@mednet.ucla.edu Principal Investigator: Zev Wainberg, MD Canada, Ontario Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Philippe Bedard, M.D. 416-946-4534 Principal Investigator: Philippe Bedard, M.D. Collapse << NCT03187288 Acute Myeloid Leukemia ... more >> Myelodysplastic Syndromes Relapsed Cancer Refractory Cancer Collapse << Phase 1 Recruiting April 4, 2022 Canada, Ontario ... more >> Juravinski Hospital and Cancer Centre Not yet recruiting Hamilton, Ontario, Canada, L8V 1C3 Contact: Brian Leber, M.D. 905-521-2100 ext 76384 Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Karen Yee, M.D. 416-946-4495 Collapse <<
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 1338806-73-7 | 储存条件 |
|
|
| 分子式 | C33H34N4O3 | 运输 | 蓝冰 | |
| 分子量 | 534.65 | 别名 | CFI-400945 Free Base |
